10. Income Taxes	9 Months Ended
Sep. 30, 2017
Notes to Financial Statements
10. Income Taxes	As of December 31, 2016 and September 30, 2017, the Company had approximately $24,223,000 and $23,799,000 of remaining net operating loss carryforwards which management had fully reserved against based on a history of unprofitable operations. Based on a change in control during December 2016, management concluded that they would be limited to utilizing net operating loss carryforwards of $895,000 per year until the balance is utilized or expired as well as other tax deferrals. During the three and nine months ended September 30, 2017, the Company utilized net operating losses and other tax deferrals of $1,001,000 and $1,425,000 to offset its net income earned during this period. The utilization of these carry-forward credits resulted in a reduction of current tax expense and an offsetting increase in the deferred tax benefit of $400,000 and $570,000 for the three and nine months ended, respectively. No tax benefit has been recognized related to the net loss in the three and nine months ended September 30, 2017 as the Company has recorded a full valuation allowance against these credits.

10. Income Taxes

9 Months Ended

Sep. 30, 2017

As of December 31, 2016 and September 30, 2017, the Company had approximately $24,223,000 and $23,799,000 of remaining net operating loss carryforwards which management had fully reserved against based on a history of unprofitable operations. Based on a change in control during December 2016, management concluded that they would be limited to utilizing net operating loss carryforwards of $895,000 per year until the balance is utilized or expired as well as other tax deferrals. During the three and nine months ended September 30, 2017, the Company utilized net operating losses and other tax deferrals of $1,001,000 and $1,425,000 to offset its net income earned during this period. The utilization of these carry-forward credits resulted in a reduction of current tax expense and an offsetting increase in the deferred tax benefit of $400,000 and $570,000 for the three and nine months ended, respectively. No tax benefit has been recognized related to the net loss in the three and nine months ended September 30, 2017 as the Company has recorded a full valuation allowance against these credits.